Company / Revenue
IDEAYA Biosciences, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$218.7M
FY2025
5-year range
$0 / $218.7M
FY2021-FY2025
Trend
+3024.4%
vs FY2024
Sector context
#89 of 155
Health Care
What the data says
Revenue changed +3024% YoY in FY2025, a notable deviation from the 4-year average annual change of +719%.
Based on SEC 10-K filings.
$219M in FY2025 with a 5-year CAGR of +62.1%.
Improved from $23M to $219M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +123.7%
- 5-Year CAGR
- +62.1%
- 10-Year CAGR
- -
Sector benchmark
#89 of 155 in Health CareTop 57% of 155This company $218.7M Sector average $4.5B
▼
-95.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +62.1%, indicating consistent growth.
- In FY2025, revenue increased 3024.4% year-over-year.
- Ranks #89 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $218.7M | +3024.4% |
| FY2024 | $7.0M | -70.1% |
| FY2023 | $23.4M | +19.7% |
| FY2022 | $19.5M | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $19.5M | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026